These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20425104)

  • 1. Direct thrombin inhibitors: pharmacology and application in intensive care medicine.
    Schaden E; Kozek-Langenecker SA
    Intensive Care Med; 2010 Jul; 36(7):1127-37. PubMed ID: 20425104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Direct thrombin inhibitors: pharmacology and application in cardiovascular anesthesia].
    Kozek-Langenecker SA
    Anaesthesist; 2008 Jun; 57(6):597-606. PubMed ID: 18311550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation strategies for patients undergoing percutaneous coronary intervention: unfractionated heparin, low-molecular-weight heparins, and direct thrombin inhibitors.
    Kokolis S; Cavusoglu E; Clark LT; Marmur JD
    Prog Cardiovasc Dis; 2004; 46(6):506-23. PubMed ID: 15224257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological strategies for inhibition of thrombin activity.
    Alban S
    Curr Pharm Des; 2008; 14(12):1152-75. PubMed ID: 18473863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and clinical potential of direct thrombin inhibitors.
    Linkins LA; Weitz JI
    Curr Pharm Des; 2005; 11(30):3877-84. PubMed ID: 16305518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of anticoagulation in the critically ill patient.
    Toale KM
    Crit Care Nurs Clin North Am; 2013 Dec; 25(4):471-80, vi. PubMed ID: 24267283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heparin-induced thrombocytopenia type II with thrombosis in an intensive care patient: therapy management using the direct thrombin inhibitor argatroban].
    Heil S
    Anaesthesist; 2009 Nov; 58(11):1119-22. PubMed ID: 19795099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
    Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
    Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Argatroban, a new antithrombotic treatment for heparin-induced thrombocytopenia application in cardiac surgery and in intensive care].
    Rozec B; Boissier E; Godier A; Cinotti R; Stephan F; Blanloeil Y
    Ann Fr Anesth Reanim; 2014; 33(9-10):514-23. PubMed ID: 25148720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Am J Cardiovasc Drugs; 2001; 1(6):429-43. PubMed ID: 14728002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticoagulation in critically ill patient].
    Fries D
    Wien Med Wochenschr; 2009 Oct; 159(19-20):487-91. PubMed ID: 19898788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Severe Bleeding in Patients Treated With Oral Anticoagulants: Proceedings Monograph From the Emergency Medicine Cardiac Research and Education Group-International Multidisciplinary Severe Bleeding Consensus Panel October 20, 2018.
    Gibler WB; Racadio JM; Hirsch AL; Roat TW
    Crit Pathw Cardiol; 2019 Sep; 18(3):143-166. PubMed ID: 31348075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia: twenty-nine years later.
    Shuster TA; Silliman WR; Coats RD; Mureebe L; Silver D
    J Vasc Surg; 2003 Dec; 38(6):1316-22. PubMed ID: 14681635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer anticoagulants in critically ill patients.
    Rajasekhar A; Beyth R; Crowther MA
    Crit Care Clin; 2012 Jul; 28(3):427-51, vii. PubMed ID: 22713616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct thrombin inhibitors for treatment of heparin induced thrombocytopenia, deep vein thrombosis and atrial fibrillation.
    Francis CW
    Curr Pharm Des; 2005; 11(30):3931-41. PubMed ID: 16305522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation: the present and future.
    Van Aken H; Bode C; Darius H; Diehm C; Encke A; Gulba DC; Haas S; Hacke W; Puhl W; Quante M; Riess H; Scharf R; Schellong S; Schrör T; Schulte KL; Tebbe U
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):195-204. PubMed ID: 11441979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists of activated factor X and thrombin: innovative antithrombotic agents.
    Franchini M; Lippi G
    Curr Vasc Pharmacol; 2007 Apr; 5(2):121-8. PubMed ID: 17430216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway?
    van Montfoort ML; Meijers JC
    Thromb Haemost; 2013 Aug; 110(2):223-32. PubMed ID: 23739841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacology of heparins and direct anticoagulants].
    Alban S
    Hamostaseologie; 2008 Dec; 28(5):400-20. PubMed ID: 19132170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Warkentin TE; Greinacher A
    Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.